nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfacetamide—Sulfapyridine—Vismodegib—skin cancer	0.848	1	CrCrCtD
Sulfacetamide—Conjunctival irritation—Imiquimod—skin cancer	0.0503	0.341	CcSEcCtD
Sulfacetamide—Stinging—Imiquimod—skin cancer	0.00517	0.0351	CcSEcCtD
Sulfacetamide—Lupus erythematosus—Docetaxel—skin cancer	0.00448	0.0304	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.00321	0.0218	CcSEcCtD
Sulfacetamide—Blister—Fluorouracil—skin cancer	0.00321	0.0218	CcSEcCtD
Sulfacetamide—Systemic lupus erythematosus—Docetaxel—skin cancer	0.00302	0.0205	CcSEcCtD
Sulfacetamide—Stinging—Fluorouracil—skin cancer	0.00286	0.0194	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00273	0.0185	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Dactinomycin—skin cancer	0.00261	0.0177	CcSEcCtD
Sulfacetamide—Pain—Vismodegib—skin cancer	0.00243	0.0165	CcSEcCtD
Sulfacetamide—Aplastic anaemia—Temozolomide—skin cancer	0.00236	0.016	CcSEcCtD
Sulfacetamide—Erythema multiforme—Vemurafenib—skin cancer	0.00233	0.0158	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00232	0.0158	CcSEcCtD
Sulfacetamide—Erythema—Vemurafenib—skin cancer	0.00215	0.0146	CcSEcCtD
Sulfacetamide—Benzocaine—SCN10A—skin cancer	0.00211	0.479	CrCbGaD
Sulfacetamide—Pruritus—Vismodegib—skin cancer	0.00201	0.0136	CcSEcCtD
Sulfacetamide—Erythema multiforme—Imiquimod—skin cancer	0.00199	0.0135	CcSEcCtD
Sulfacetamide—Erythema—Imiquimod—skin cancer	0.00183	0.0124	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00182	0.0123	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Fluorouracil—skin cancer	0.00176	0.0119	CcSEcCtD
Sulfacetamide—Infection—Vemurafenib—skin cancer	0.00174	0.0118	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00164	0.0111	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00154	0.0104	CcSEcCtD
Sulfacetamide—Oedema—Imiquimod—skin cancer	0.0015	0.0101	CcSEcCtD
Sulfacetamide—Infection—Imiquimod—skin cancer	0.00149	0.0101	CcSEcCtD
Sulfacetamide—Agranulocytosis—Dactinomycin—skin cancer	0.00145	0.00984	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00139	0.00945	CcSEcCtD
Sulfacetamide—Procainamide—SCN10A—skin cancer	0.00138	0.312	CrCbGaD
Sulfacetamide—Erythema multiforme—Dactinomycin—skin cancer	0.00132	0.00895	CcSEcCtD
Sulfacetamide—Erythema—Bleomycin—skin cancer	0.0013	0.00883	CcSEcCtD
Sulfacetamide—Hypersensitivity—Vemurafenib—skin cancer	0.00129	0.00877	CcSEcCtD
Sulfacetamide—Pain—Imiquimod—skin cancer	0.00128	0.00868	CcSEcCtD
Sulfacetamide—Dermatitis bullous—Docetaxel—skin cancer	0.00127	0.00861	CcSEcCtD
Sulfacetamide—Pruritus—Vemurafenib—skin cancer	0.00124	0.00842	CcSEcCtD
Sulfacetamide—Erythema—Dactinomycin—skin cancer	0.00121	0.00824	CcSEcCtD
Sulfacetamide—Agranulocytosis—Fluorouracil—skin cancer	0.00121	0.0082	CcSEcCtD
Sulfacetamide—Erythema multiforme—Temozolomide—skin cancer	0.00119	0.00809	CcSEcCtD
Sulfacetamide—Hypersensitivity—Imiquimod—skin cancer	0.0011	0.00748	CcSEcCtD
Sulfacetamide—Erythema—Temozolomide—skin cancer	0.0011	0.00745	CcSEcCtD
Sulfacetamide—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00109	0.00741	CcSEcCtD
Sulfacetamide—Oedema—Bleomycin—skin cancer	0.00106	0.00721	CcSEcCtD
Sulfacetamide—Pruritus—Imiquimod—skin cancer	0.00106	0.00718	CcSEcCtD
Sulfacetamide—Infection—Bleomycin—skin cancer	0.00106	0.00716	CcSEcCtD
Sulfacetamide—Erythema—Fluorouracil—skin cancer	0.00101	0.00686	CcSEcCtD
Sulfacetamide—Oedema—Dactinomycin—skin cancer	0.000991	0.00672	CcSEcCtD
Sulfacetamide—Infection—Dactinomycin—skin cancer	0.000984	0.00668	CcSEcCtD
Sulfacetamide—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000926	0.00629	CcSEcCtD
Sulfacetamide—Pain—Bleomycin—skin cancer	0.000909	0.00616	CcSEcCtD
Sulfacetamide—Oedema—Temozolomide—skin cancer	0.000896	0.00608	CcSEcCtD
Sulfacetamide—Infection—Temozolomide—skin cancer	0.00089	0.00604	CcSEcCtD
Sulfacetamide—Agranulocytosis—Docetaxel—skin cancer	0.000872	0.00592	CcSEcCtD
Sulfacetamide—Pain—Dactinomycin—skin cancer	0.000847	0.00575	CcSEcCtD
Sulfacetamide—Oedema—Fluorouracil—skin cancer	0.000826	0.0056	CcSEcCtD
Sulfacetamide—Infection—Fluorouracil—skin cancer	0.00082	0.00557	CcSEcCtD
Sulfacetamide—Erythema multiforme—Docetaxel—skin cancer	0.000793	0.00538	CcSEcCtD
Sulfacetamide—Hypersensitivity—Bleomycin—skin cancer	0.000783	0.00531	CcSEcCtD
Sulfacetamide—Pain—Temozolomide—skin cancer	0.000766	0.0052	CcSEcCtD
Sulfacetamide—Pruritus—Bleomycin—skin cancer	0.000752	0.0051	CcSEcCtD
Sulfacetamide—Erythema—Docetaxel—skin cancer	0.00073	0.00495	CcSEcCtD
Sulfacetamide—Hypersensitivity—Dactinomycin—skin cancer	0.00073	0.00495	CcSEcCtD
Sulfacetamide—Pain—Fluorouracil—skin cancer	0.000706	0.00479	CcSEcCtD
Sulfacetamide—Hypersensitivity—Temozolomide—skin cancer	0.00066	0.00448	CcSEcCtD
Sulfacetamide—Pruritus—Temozolomide—skin cancer	0.000634	0.0043	CcSEcCtD
Sulfacetamide—Hypersensitivity—Fluorouracil—skin cancer	0.000608	0.00413	CcSEcCtD
Sulfacetamide—Oedema—Docetaxel—skin cancer	0.000596	0.00404	CcSEcCtD
Sulfacetamide—Infection—Docetaxel—skin cancer	0.000592	0.00402	CcSEcCtD
Sulfacetamide—Pruritus—Fluorouracil—skin cancer	0.000584	0.00396	CcSEcCtD
Sulfacetamide—Acetaminophen—PTGS2—skin cancer	0.000554	0.126	CrCbGaD
Sulfacetamide—Pain—Docetaxel—skin cancer	0.00051	0.00346	CcSEcCtD
Sulfacetamide—Hypersensitivity—Docetaxel—skin cancer	0.000439	0.00298	CcSEcCtD
Sulfacetamide—Pruritus—Docetaxel—skin cancer	0.000422	0.00286	CcSEcCtD
Sulfacetamide—Dapsone—PTGS2—skin cancer	0.000363	0.0823	CrCbGaD
